Causes and Treatment Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in 82 Adult Patients

The current understanding of Stevens–Johnson syndrome and toxic epidermal necrolysis

(2011) Maja Mockenhaupt   Expert Review of Clinical Immunology

Clinical, Etiologic, and Histopathologic Features of Stevens-Johnson Syndrome During an 8-Year Period at Mayo Clinic

(2010) David A. Wetter et al.   MAYO CLINIC PROCEEDINGS

Comparison of the Causes and Clinical Features of Drug Rash With Eosinophilia and Systemic Symptoms and Stevens-Johnson Syndrome

(2010) Yun-Jin Jeung et al.   Allergy Asthma & Immunology Research

Successful Treatment of Stevens-Johnson Syndrome with Steroid Pulse Therapy at Disease Onset

(2009) Yayoi Araki et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Stevens–Johnson syndrome and toxic epidermal necrolysis

(2008) Andrea T. Borchers et al.   AUTOIMMUNITY REVIEWS

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

(2007) Maja Mockenhaupt et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study

(2007) Jürgen Schneck et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY